ID   H2AY_RAT                Reviewed;         368 AA.
AC   Q02874; O09140; Q63325;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   12-OCT-2022, sequence version 5.
DT   24-JUL-2024, entry version 189.
DE   RecName: Full=Core histone macro-H2A.1;
DE            Short=Histone macroH2A1;
DE            Short=mH2A1;
DE   AltName: Full=H2A.y;
DE   AltName: Full=H2A/y;
GN   Name=Macroh2a1 {ECO:0000312|RGD:621462};
GN   Synonyms=H2afy {ECO:0000312|RGD:621462};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND PARTIAL PROTEIN
RP   SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=1529340; DOI=10.1126/science.1529340;
RA   Pehrson J.R., Fried V.A.;
RT   "MacroH2A, a core histone containing a large nonhistone region.";
RL   Science 257:1398-1400(1992).
RN   [2]
RP   SEQUENCE REVISION (ISOFORM 1).
RA   Pehrson J.R.;
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Thymus;
RX   PubMed=9138085;
RX   DOI=10.1002/(sici)1097-4644(199704)65:1<107::aid-jcb11>3.0.co;2-h;
RA   Pehrson J.R., Costanzi C., Dharia C.;
RT   "Developmental and tissue expression patterns of histone macroH2A1
RT   subtypes.";
RL   J. Cell. Biochem. 65:107-113(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=Brown Norway; TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 181-371 (ISOFORM 1), AND FUNCTION.
RX   PubMed=16107708; DOI=10.1128/mcb.25.17.7616-7624.2005;
RA   Chakravarthy S., Gundimella S.K., Caron C., Perche P.-Y., Pehrson J.R.,
RA   Khochbin S., Luger K.;
RT   "Structural characterization of the histone variant macroH2A.";
RL   Mol. Cell. Biol. 25:7616-7624(2005).
CC   -!- FUNCTION: Variant histone H2A which replaces conventional H2A in a
CC       subset of nucleosomes where it represses transcription. Nucleosomes
CC       wrap and compact DNA into chromatin, limiting DNA accessibility to the
CC       cellular machineries which require DNA as a template (PubMed:16107708).
CC       Histones thereby play a central role in transcription regulation, DNA
CC       repair, DNA replication and chromosomal stability (PubMed:16107708).
CC       DNA accessibility is regulated via a complex set of post-translational
CC       modifications of histones, also called histone code, and nucleosome
CC       remodeling (PubMed:16107708). Involved in stable X chromosome
CC       inactivation. Inhibits the binding of transcription factors, including
CC       NF-kappa-B, and interferes with the activity of remodeling SWI/SNF
CC       complexes (By similarity). Inhibits histone acetylation by EP300 and
CC       recruits class I HDACs, which induces a hypoacetylated state of
CC       chromatin (By similarity). {ECO:0000250|UniProtKB:O75367,
CC       ECO:0000250|UniProtKB:Q9QZQ8, ECO:0000269|PubMed:16107708}.
CC   -!- FUNCTION: [Isoform 1]: Isoform that specifically binds poly-ADP-ribose
CC       and O-acetyl-ADP-ribose and plays a key role in NAD(+) metabolism. Able
CC       to bind to the ends of poly-ADP-ribose chains created by PARP1 and cap
CC       them. This prevents PARP1 from further addition of ADP-ribose and thus
CC       limits the consumption of nuclear NAD(+), allowing the cell to maintain
CC       proper NAD(+) levels in both the nucleus and the mitochondria to
CC       promote proper mitochondrial respiration. Increases the expression of
CC       genes involved in redox metabolism, including SOD3.
CC       {ECO:0000250|UniProtKB:Q9QZQ8}.
CC   -!- FUNCTION: [Isoform 2]: In contrast to isoform 1, does not bind poly-
CC       ADP-ribose. Represses SOD3 gene expression.
CC       {ECO:0000250|UniProtKB:Q9QZQ8}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. Interacts with HDAC1 and HDAC2. Interacts
CC       with SPOP. Part of a complex consisting of MACROH2A1, CUL3 and SPOP.
CC       {ECO:0000250|UniProtKB:O75367}.
CC   -!- SUBUNIT: [Isoform 1]: Interacts with PARP1.
CC       {ECO:0000250|UniProtKB:Q9QZQ8}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75367}.
CC       Chromosome {ECO:0000250|UniProtKB:O75367}. Note=Enriched in inactive X
CC       chromosome chromatin and in senescence-associated heterochromatin.
CC       Recruited to DNA damage sites in an APLF-dependent manner.
CC       {ECO:0000250|UniProtKB:O75367}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=mH2A1.1;
CC         IsoId=Q02874-2; Sequence=Displayed;
CC       Name=2; Synonyms=mH2A1.2;
CC         IsoId=Q02874-1; Sequence=VSP_061612;
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Present only in liver and brain (at
CC       protein level). {ECO:0000269|PubMed:9138085}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Present in brain, thymus, testis,
CC       liver and kidney (at protein level). {ECO:0000269|PubMed:9138085}.
CC   -!- DOMAIN: [Isoform 1]: The macro domain specifically binds poly-ADP-
CC       ribose. {ECO:0000250|UniProtKB:O75367}.
CC   -!- PTM: Monoubiquitinated at either Lys-116 or Lys-117. May also be
CC       polyubiquitinated. Ubiquitination is mediated by the CUL3/SPOP E3
CC       complex and does not promote proteasomal degradation. Instead, it is
CC       required for enrichment in inactive X chromosome chromatin.
CC       {ECO:0000250|UniProtKB:O75367}.
CC   -!- SIMILARITY: Belongs to the histone H2A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M99065; AAA41561.2; -; mRNA.
DR   EMBL; M99066; AAA41560.1; -; mRNA.
DR   EMBL; U79139; AAB38330.1; -; mRNA.
DR   EMBL; BC089093; AAH89093.1; -; mRNA.
DR   PIR; I59567; I59567.
DR   PIR; I80811; I80811.
DR   RefSeq; NP_058878.1; NM_017182.2. [Q02874-1]
DR   RefSeq; XP_006253638.1; XM_006253576.3.
DR   PDB; 1YD9; X-ray; 1.60 A; A/B/C/D=226-368.
DR   PDBsum; 1YD9; -.
DR   AlphaFoldDB; Q02874; -.
DR   SMR; Q02874; -.
DR   BioGRID; 248036; 2.
DR   IntAct; Q02874; 1.
DR   MINT; Q02874; -.
DR   STRING; 10116.ENSRNOP00000049143; -.
DR   iPTMnet; Q02874; -.
DR   PhosphoSitePlus; Q02874; -.
DR   jPOST; Q02874; -.
DR   PaxDb; 10116-ENSRNOP00000049143; -.
DR   Ensembl; ENSRNOT00000051702.7; ENSRNOP00000049143.4; ENSRNOG00000011523.9. [Q02874-1]
DR   GeneID; 29384; -.
DR   KEGG; rno:29384; -.
DR   UCSC; RGD:621462; rat. [Q02874-2]
DR   AGR; RGD:621462; -.
DR   CTD; 9555; -.
DR   RGD; 621462; Macroh2a1.
DR   eggNOG; KOG1756; Eukaryota.
DR   eggNOG; KOG2633; Eukaryota.
DR   GeneTree; ENSGT00940000159541; -.
DR   HOGENOM; CLU_062828_0_0_1; -.
DR   InParanoid; Q02874; -.
DR   OMA; GHNFPAK; -.
DR   OrthoDB; 235643at2759; -.
DR   PhylomeDB; Q02874; -.
DR   EvolutionaryTrace; Q02874; -.
DR   PRO; PR:Q02874; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Bgee; ENSRNOG00000011523; Expressed in thymus and 20 other cell types or tissues.
DR   ExpressionAtlas; Q02874; baseline and differential.
DR   GO; GO:0001740; C:Barr body; ISO:RGD.
DR   GO; GO:0000785; C:chromatin; IDA:RGD.
DR   GO; GO:0000793; C:condensed chromosome; ISO:RGD.
DR   GO; GO:0000228; C:nuclear chromosome; ISO:RGD.
DR   GO; GO:0005730; C:nucleolus; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0000786; C:nucleosome; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005721; C:pericentric heterochromatin; ISO:RGD.
DR   GO; GO:0090734; C:site of DNA damage; ISO:RGD.
DR   GO; GO:0072570; F:ADP-D-ribose binding; ISS:UniProtKB.
DR   GO; GO:0160002; F:ADP-D-ribose modification-dependent protein binding; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0010385; F:double-stranded methylated DNA binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0031492; F:nucleosomal DNA binding; ISO:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0030291; F:protein serine/threonine kinase inhibitor activity; ISO:RGD.
DR   GO; GO:0000182; F:rDNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0030527; F:structural constituent of chromatin; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0006281; P:DNA repair; ISO:RGD.
DR   GO; GO:0040029; P:epigenetic regulation of gene expression; ISO:RGD.
DR   GO; GO:0071169; P:establishment of protein localization to chromatin; ISO:RGD.
DR   GO; GO:0031507; P:heterochromatin formation; IBA:GO_Central.
DR   GO; GO:1902750; P:negative regulation of cell cycle G2/M phase transition; ISO:RGD.
DR   GO; GO:0045814; P:negative regulation of gene expression, epigenetic; ISO:RGD.
DR   GO; GO:1904815; P:negative regulation of protein localization to chromosome, telomeric region; ISO:RGD.
DR   GO; GO:1902883; P:negative regulation of response to oxidative stress; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:1901837; P:negative regulation of transcription of nucleolar large rRNA by RNA polymerase I; ISO:RGD.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:1903226; P:positive regulation of endodermal cell differentiation; ISO:RGD.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0034184; P:positive regulation of maintenance of mitotic sister chromatid cohesion; ISO:RGD.
DR   GO; GO:1902884; P:positive regulation of response to oxidative stress; ISO:RGD.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; ISO:RGD.
DR   GO; GO:1902688; P:regulation of NAD metabolic process; ISS:UniProtKB.
DR   GO; GO:0002082; P:regulation of oxidative phosphorylation; ISO:RGD.
DR   GO; GO:1902882; P:regulation of response to oxidative stress; ISO:RGD.
DR   GO; GO:0007549; P:sex-chromosome dosage compensation; ISO:RGD.
DR   GO; GO:0045815; P:transcription initiation-coupled chromatin remodeling; ISO:RGD.
DR   CDD; cd00074; H2A; 1.
DR   CDD; cd02904; Macro_H2A-like; 1.
DR   Gene3D; 1.10.20.10; Histone, subunit A; 1.
DR   Gene3D; 3.40.220.10; Leucine Aminopeptidase, subunit E, domain 1; 1.
DR   InterPro; IPR021171; Core_histone_macro-H2A.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR002119; Histone_H2A.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR032454; Histone_H2A_C.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR043472; Macro_dom-like.
DR   InterPro; IPR035796; Macro_H2A.
DR   PANTHER; PTHR23430:SF20; CORE HISTONE MACRO-H2A.1; 1.
DR   PANTHER; PTHR23430; HISTONE H2A; 1.
DR   Pfam; PF00125; Histone; 1.
DR   Pfam; PF16211; Histone_H2A_C; 1.
DR   Pfam; PF01661; Macro; 1.
DR   PIRSF; PIRSF037942; Core_histone_macro-H2A; 1.
DR   PRINTS; PR00620; HISTONEH2A.
DR   SMART; SM00506; A1pp; 1.
DR   SMART; SM00414; H2A; 1.
DR   SUPFAM; SSF47113; Histone-fold; 1.
DR   SUPFAM; SSF52949; Macro domain-like; 1.
DR   PROSITE; PS51154; MACRO; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Chromosome; Direct protein sequencing; DNA-binding; Isopeptide bond;
KW   Methylation; Nucleosome core; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN           1..368
FT                   /note="Core histone macro-H2A.1"
FT                   /id="PRO_0000055319"
FT   DOMAIN          2..117
FT                   /note="Histone H2A"
FT   DOMAIN          183..366
FT                   /note="Macro"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00490"
FT   REGION          128..179
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        140..155
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        165..179
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         202
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0D2UG83"
FT   BINDING         203
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0D2UG83"
FT   BINDING         225
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0D2UG83"
FT   BINDING         274
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0D2UG83"
FT   BINDING         311
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0D2UG83"
FT   BINDING         312
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0D2UG83"
FT   BINDING         313
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0D2UG83"
FT   BINDING         315
FT                   /ligand="a glycoprotein"
FT                   /ligand_id="ChEBI:CHEBI:17089"
FT                   /ligand_part="poly[(1''->2')-ADP-alpha-D-ribose] group"
FT                   /ligand_part_id="ChEBI:CHEBI:157741"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0D2UG83"
FT   MOD_RES         7
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0C0S5"
FT   MOD_RES         9
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0C0S5"
FT   MOD_RES         18
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   MOD_RES         116
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZQ8"
FT   MOD_RES         123
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   MOD_RES         123
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZQ8"
FT   MOD_RES         129
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         172
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   CROSSLNK        116
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   CROSSLNK        117
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   CROSSLNK        123
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   CROSSLNK        166
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   CROSSLNK        188
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   CROSSLNK        319
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O75367"
FT   VAR_SEQ         197..225
FT                   /note="QVVQADIASIDSDAVVHPTNADFYIGGEV -> NLIHSEISNLAGFEVEAII
FT                   NPTNADIDLKDDL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1529340"
FT                   /id="VSP_061612"
FT   STRAND          184..189
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   STRAND          195..199
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   STRAND          209..214
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   HELIX           224..248
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   STRAND          256..260
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   STRAND          264..272
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   HELIX           282..299
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   STRAND          303..307
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   STRAND          311..313
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   HELIX           319..334
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   STRAND          344..348
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   HELIX           352..362
FT                   /evidence="ECO:0007829|PDB:1YD9"
FT   TURN            363..366
FT                   /evidence="ECO:0007829|PDB:1YD9"
SQ   SEQUENCE   368 AA;  39040 MW;  59ACA1B086CF5C69 CRC64;
     MSSRGGKKKS TKTSRSAKAG VIFPVGRMLR YIKKGHPKYR IGVGAPVYMA AVLEYLTAEI
     LELAGNAARD NKKGRVTPRH ILLAVANDEE LNQLLKGVTI ASGGVLPNIH PELLAKKRGS
     KGKLEAIITP PPAKKAKSPS QKKPVAKKTG GKKGARKSKK QGEVSKAASA DSTTEGAPTD
     GFTVLSTKSL FLGQKLQVVQ ADIASIDSDA VVHPTNADFY IGGEVGSTLE KKGGKEFVEA
     VLELRKKNGP LEVAGAAVSA GHGLPAKFVI HCNSPVWGAD KCEELLEKTV KNCLALADDR
     KLKSIAFPSI GSGRNGFPKQ TAAQLILKAI SSYFVSTMSS SIKTVYFVLF DSESIGIYVQ
     EMAKLDAN
//
